AbbVie Defeats Investor Class Suit Alleging Humira Kickbacks

By Rae Ann Varona · July 11, 2025, 9:51 PM EDT

AbbVie on Thursday defeated a certified securities class action that accused it of giving healthcare providers unlawful kickbacks in exchange for prescribing its flagship arthritis drug Humira when an Illinois federal...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login